These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of bisphosphonates in the treatment of bone metastases--the U.S. experience. Harvey HA; Lipton A Support Care Cancer; 1996 May; 4(3):213-7. PubMed ID: 8739655 [TBL] [Abstract][Full Text] [Related]
3. The future of bisphosphonates in cancer. Coleman RE; Purohit OP; Vinholes JJ Acta Oncol; 1996; 35 Suppl 5():23-9. PubMed ID: 9142961 [TBL] [Abstract][Full Text] [Related]
4. [Pamidronate in the treatment of bone metastases from breast cancer]. Nagykálnai T; Landherr L; Zatkóné GP; Gyuricska A Magy Onkol; 2002; 46(3):225-33. PubMed ID: 12368918 [TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates for breast cancer. Pavlakis N; Stockler M Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical endpoints. Major PP; Cook R Am J Clin Oncol; 2002 Dec; 25(6 Suppl 1):S10-8. PubMed ID: 12562046 [TBL] [Abstract][Full Text] [Related]
7. [Bisphosphonates and bone metastases]. Lortholary A; Jadaud E; Berthaud P Bull Cancer; 1999 Sep; 86(9):732-8. PubMed ID: 10519966 [TBL] [Abstract][Full Text] [Related]
8. [Bisphosphonates in oncology]. Kurth AA; Heidenreich A; Diel I Orthopade; 2007 Feb; 36(2):131-5. PubMed ID: 17252255 [TBL] [Abstract][Full Text] [Related]
9. Oral bisphosphonates: A review of clinical use in patients with bone metastases. Major PP; Lipton A; Berenson J; Hortobagyi G Cancer; 2000 Jan; 88(1):6-14. PubMed ID: 10618600 [TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates in the treatment of malignant bone disease. Berenson JR; Lipton A Annu Rev Med; 1999; 50():237-48. PubMed ID: 10073275 [TBL] [Abstract][Full Text] [Related]
11. New results from the use of bisphosphonates in cancer patients. Coleman R; Gnant M Curr Opin Support Palliat Care; 2009 Sep; 3(3):213-8. PubMed ID: 19561507 [TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates in the prevention and treatment of bone metastases. Ramaswamy B; Shapiro CL Oncology (Williston Park); 2003 Sep; 17(9):1261-70; discussion 1270-2, 1277-8, 1280. PubMed ID: 14569853 [TBL] [Abstract][Full Text] [Related]
13. Rationale for the use of bisphosphonates in breast cancer. Kanis JA Acta Oncol; 1996; 35 Suppl 5():61-7. PubMed ID: 9142969 [TBL] [Abstract][Full Text] [Related]
14. The use of bisphosphonates in patients with breast cancer. Van Poznak CH Cancer Control; 2002; 9(6):480-9. PubMed ID: 12514566 [TBL] [Abstract][Full Text] [Related]
15. Pharmacology and clinical efficacy of bisphosphonates. Berenson JR; Lipton A Curr Opin Oncol; 1998 Nov; 10(6):566-71. PubMed ID: 9818237 [TBL] [Abstract][Full Text] [Related]
16. Use of bisphosphonates in patients with metastatic bone disease. Berenson JR; Lipton A Oncology (Williston Park); 1998 Nov; 12(11):1573-9; discussion 1579-81. PubMed ID: 9834935 [TBL] [Abstract][Full Text] [Related]
17. Combined therapies of bone disease with bisphosphonates. Syddall SP; Ottewell PD; Holen I Curr Pharm Des; 2010; 16(27):2988-97. PubMed ID: 20722617 [TBL] [Abstract][Full Text] [Related]
18. Utility of bisphosphonates in treating bone metastases. Merlini G; Turesson I Med Oncol; 1996 Dec; 13(4):215-21. PubMed ID: 9152972 [TBL] [Abstract][Full Text] [Related]